0000885590-13-000073.txt : 20130816
0000885590-13-000073.hdr.sgml : 20130816
20130816161048
ACCESSION NUMBER: 0000885590-13-000073
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130816
FILED AS OF DATE: 20130816
DATE AS OF CHANGE: 20130816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schiller Howard Bradley
CENTRAL INDEX KEY: 0001536053
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 131045449
MAIL ADDRESS:
STREET 1: 4787
CITY: MONTREAL
STATE: A8
ZIP: H4R 2P9
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2013-08-16
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001536053
Schiller Howard Bradley
2150 ST. ELZEAR BLVD. WEST
LAVAL
A8
H7L 4A8
QUEBEC, CANADA
0
1
0
0
EVP and CFO
Common Stock, no par values
2013-08-16
4
M
0
90000
0
A
279218
D
Common Stock, no par values
2013-08-16
4
F
0
45230
0
D
233988
D
Restricted Share Units
0
2013-08-16
4
M
0
90000
0
D
Common Stock
90000
90000
D
This represents a one-time payout of common shares issued upon the accelerated vesting of performance-based RSUs ("PSUs") that were previously reported. The initial grant was reported to vest based on total shareholder return (TSR) between a price of $42.70 starting on December 1, 2011 and the average stock price for the prior 20 trading days as of three measurement dates: 25% would vest on September 1, 2014, 50% on December 1, 2014 and 25% on March 1, 2014. Unit vesting is contingent on TSR performance between 15% and 45% into between one and three shares of common stock, respectively, with early vesting possible at higher TSR levels. Additional common shares pursuant to this award of PSUs may be earned upon the future achievement of TSR performance targets.
This number represents common shares purchased by the officer, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1.
This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Performance Share Units.
by: Nicholas Zanoni for Howard Schiller
2013-08-16